In a letter this week to its suppliers, McKesson—the largest pharmaceutical distributor in the United States—addressed their expectations relating to ...

While increased healthcare spend will likely lead to higher revenues for manufacturers, life sciences companies will focus heavily on addressing ...

Launching a new, undifferentiated drug in a mature and highly regulated market can be challenging—even for an established organization. Facing the ...

The leadership team of a multinational healthcare company was dissatisfied with the organization’s ability to realize true value from its large scale. ...

The consumer products industry is a challenging and complex environment. The ultimate goal is profit and the ultimate plan to maximize ...

Seasonality is alive and well in the consumer products industry. Most relevant this week, with the 31st of October fast ...

As we continue our discussion about trade spend, we take a more in-depth look at the role of capital allocation in ...

As pharmaceutical companies introduce new therapies to the U.S. market, they respond to risk-sharing agreements (RSAs) from healthcare providers, which ...

Last year, products with sustainability claims on packaging experienced double the amount of global sales growth than those without. Process improvement and stabilization are ...

As we continue our “State of Brands” blog series, we’ve decided to expound upon a recent Clarkston report, Trade Spend’s ...

For any enterprise involved in manufacturing, maintenance costs are a significant portion of business expenses. Often, this cost is reluctantly ...

Among the challenges faced by the generic industry is the trend of wholesaler and pharmacy partnerships, alignment and amassing of scale. ...